A biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders.

Sectors
Healthcare
Life Sciences
First Invested
2021
Public/PIPES
Company Status
NASDAQ: VTGN